Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 8, 2003, Pages 2685-2687

  Bermudez, Luiz E ^a,b   Reynolds, Robert ^c   Kolonoski, Peter ^a   Aralar, Pricilla ^d   Inderlied, Clark B ^d,e   Young, Lowell S ^a  

^a Kuzell Institute for Arthritis and Infectious Diseases   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c SOUTHERN RESEARCH INSTITUTE   (United States)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOXIFLOXACIN; SRI 224; SRI 286; THIOACETAZONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG SCREENING; DRUG TISSUE LEVEL; FEMALE; LIVER; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

ANIMALS; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; COLONY COUNT, MICROBIAL; DRUG THERAPY, COMBINATION; FLUOROQUINOLONES; HUMANS; LIVER; MICE; MICE, INBRED C57BL; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; QUINOLINES; SPLEEN; THIOACETAZONE;

EID: 0041767396     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.8.2685-2687.2003     Document Type: Article

References (17)

1. Bermudez, L. E., C. B. Inderlied, P. Kolonoski, M. Petrofsky, P. Aralar, M. Wu, and L. S. Young. 2001. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium. Antimicrob. Agents Chemother. 45:217-222.
2. Bermudez, L. E., C. B. Inderlied, P. Kolonoski, M. Wu, P. Aralar, and L. S. Young. 2001. Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment. Antimicrob. Agents Chemother. 45:2210-2214.
3. Bermudez, L. E., P. Kolonoski, and L. S. Young. 1996. Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice. Antimicrob. Agents Chemother. 40:1033-1035.
4. Bertram, M. A., C. B. Inderlied, S. Yadegar, P. Kolanoski, J. K. Yamada, and L. S. Young. 1986. Confirmation of the beige mouse model for study of disseminated infection with Mycobacterium avium complex. J. Infect. Dis. 154:194-195.
5. Chaisson, R. E., C. A. Benson, M. P. Dube, L. B. Heifets, J. A. Korvick, S. Elkin, T. Smith, J. C. Craft, F. R. Sattler, et al. 1994. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. Ann. Intern. Med. 121:905-911.
6. Council, E. A. B. M. R. 1963. Thiacetazone investigation: isoniazid with thiacetazone in the treatment of pulmonary tuberculosis in East Africa second investigation. Tubercle 44:301-333.
7. Heifets, L. B., P. J. Lindholm-Levy, and M. Flory. 1990. Thiacetazone: in vitro activity against Mycobacterium avium and M. tuberculosis. Tubercle 71:287-291.
8. Houston, S., and A. Fanning. 1994. Current and potential treatment of tuberculosis. Drugs 48:689-708.
9. Inderlied, C. B., C. A. Kemper, and L. E. Bermudez. 1993. The Mycobacterium avium complex. Clin. Microbiol. Rev. 6:266-310.
10. Inderlied, C. B., L. S. Young, and J. K. Yamada. 1987. Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimycobacterial agents by various methods. Antimicrob. Agents Chemother. 31:1697-1702.
11. Koletar, S. L. 1997. Treatment of Mycobacterium avium in human immunodeficiency virus-infected individuals. Am. J. Med. 102:16-21.
12. McGarvey, J., and L. E. Bermudez. 2002. Pathogenesis. In A. Catanzaro and C. Daley (ed.), Lung disease due to mycobacteria other than tuberculosis. Clinics in Chest Medicine, New York, N.Y.
13. Miltner, E. C., and L. E. Bermudez. 2000. Mycobacterium avium grown in Acanthamoeba castellanii is protected from the effects of antimicrobials. Antimicrob. Agents Chemother. 44:1990-1994.
14. Prince, D. S., D. D. Peterson, R. M. Steiner, J. E. Gottlieb, R. Scott, H. L. Israel, W. G. Figueroa, and J. E. Fish. 1989. Infection with Mycobacterium avium complex in patients without predisposing conditions. N. Engl. J. Med. 321:863-868.
15. Rosenweig, D. Y. 1979. Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex. Chest 75:115-119.
16. Wolinsky, E. 1979. Nontuberculous mycobacteria and associated diseases. Am. Rev. Respir. Dis. 119:107-159.
17. Young, L. S., L. Wiviott, M. Wu, P. Kolonoski, R. Bolan, and C. B. Inderlied. 1991. Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS. Lancet 338:1107-1109.